In Sweden a multidisciplinary team of researchers led from Karolinska Institutet have developed an anti-inflammatory drug molecule with a new mechanism of action. According to the Economic Times report the researchers were able to reduce the signals that trigger an inflammation by inhibiting a certain protein. The study was done in collaboration with the University of Texas Medical Branch Uppsala University and Stockholm University and was published in Science. Professor Thomas Helleday at the Department of Oncology-Pathology Karolinska Institutet Sweden who co-led the study with Dr Torkild Visnes and Dr Armando C zares-K rner reportedly said that they have developed